Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly

European Journal of Nutrition

Volumn 54, Issue 3, 2015, Pages 455-464

  Wang, Linlin ^a   Li, Hongtian ^a   Zhou, Yuan ^b   Jin, Lei ^a   Liu, Jianmeng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Xiacheng District Institute of Health Inspection   (China)

Author keywords

B vitamins; Cardiovascular disease risk; Framingham risk score; Prevention

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRIDOXINE; TRIACYLGLYCEROL; VITAMIN B COMPLEX;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASES; CHINA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; FOLIC ACID DEFICIENCY; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84939894381     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0729-5     Document Type: Article

References (41)

1. Ueland PM, Loscalzo J (2012) Homocysteine and cardiovascular risk: the perils of reductionism in a complex system. Clin Chem 58:1623–1625
2. McCully KS (2007) Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr 86:1563S–1568S
3. Hustad S, Midttun O, Schneede J, Vollset SE, Grotmol T, Ueland PM (2007) The methylenetetrahydrofolate reductase 677C→T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet 80:846–855
4. Robinson K (2004) Renal disease, homocysteine, and cardiovascular complications. Circulation 109:294–295
5. Durga J, Bots ML, Schouten EG, Grobbee DE, Kok FJ, Verhoef P (2011) Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Am J Clin Nutr 93:941–949
6. 12 vs. placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 303:2486–2494
7. Clarke R, Halsey J, Bennett D, Lewington S (2011) Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis 34:83–91
8. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578–1588
9. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567–1577
10. The VITATOPS Trial Study Group (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9:855–865
11. 6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279:359–364
12. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT (2001) Low dietary folate intake is associated with an excess incidence of acute coronary events: the Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 103:2674–2680
13. Lee M, Hong KS, Chang SC, Saver JL (2010) Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis. Stroke 41:1205–1212
14. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369:1876–1882
15. 12 and vascular disease (Docket No. 99P-3029). http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm072865.htm#tab
16. US Food and Drug Administration (2001) Settlement reached for health claim relating B vitamins and vascular disease. http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm072855.htm
17. Elshorbagy AK, Oulhaj A, Konstantinova S, Nurk E, Ueland PM, Tell GS, Nygard O, Vollset SE, Refsum H (2007) Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: use of statistical modeling to determine reference limits. Clin Biochem 40:1209–1218
18. Gale CR, Ashurst H, Phillips NJ, Moat SJ, Bonham JR, Martyn CN (2001) Renal function, plasma homocysteine and carotid atherosclerosis in elderly people. Atherosclerosis 154:141–146
19. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection E, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421
20. House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, Dresser GK, Spence JD (2010) Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 303:1603–1609
21. Tighe P, Ward M, McNulty H, Finnegan O, Dunne A, Strain J, Molloy AM, Duffy M, Pentieva K, Scott JM (2011) A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. Am J Clin Nutr 93:11–18
22. O’Broin S, Kelleher B (1992) Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol 45:344–347
23. Petrie JC, O’Brien ET, Littler WA, de Swiet M (1986) Recommendations on blood pressure measurement. Br Med J (Clin Res Ed) 293:611–615
24. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847
25. Collaboration Homocysteine Lowering Trialists’ (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82:806–812
26. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39:1764–1779
27. Federation of American Societies for Experimental Biology (1984) Assessment of the folate nutritional status of the U.S. population based on data collected in the second National Health and Nutrition Examination Survey, 1976–1980. Federation of American Societies for Experimental Biology, Bethesda, MD
28. Izzo R, de Simone G, Giudice R, Chinali M, Trimarco V, De Luca N, Trimarco B (2010) Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia. J Hypertens 28:1482–1487
29. Bhupathiraju SN, Tucker KL (2011) Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults. Am J Clin Nutr 93:37–46
30. 6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 355:517–522
31. Morrison KM, Atkinson SA, Yusuf S, Bourgeois J, McDonald S, McQueen MJ, Persadie R, Hunter B, Pogue J, Teo K (2009) The Family Atherosclerosis Monitoring In early life (FAMILY) study: rationale, design, and baseline data of a study examining the early determinants of atherosclerosis. Am Heart J 158:533–539
32. Wilcken DE, Dudman NP, Tyrrell PA, Robertson MR (1988) Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 37:697–701
33. Verhaar MC, Stroes E, Rabelink TJ (2002) Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol 22:6–13
34. Villa P, Perri C, Suriano R, Cucinelli F, Panunzi S, Ranieri M, Mele C, Lanzone A (2005) L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab 90:4622–4629
35. Paradisi G, Cucinelli F, Mele MC, Barini A, Lanzone A, Caruso A (2004) Endothelial function in post-menopausal women: effect of folic acid supplementation. Hum Reprod 19:1031–1035
36. Imamura A, Murakami R, Takahashi R, Cheng XW, Numaguchi Y, Murohara T, Okumura K (2010) Low folate levels may be an atherogenic factor regardless of homocysteine levels in young healthy nonsmokers. Metabolism 59:728–733
37. Tran-Dinh A, Diallo D, Delbosc S, Varela-Perez LM, Dang QB, Lapergue B, Burillo E, Michel JB, Levoye A, Martin-Ventura JL, Meilhac O (2013) HDL and endothelial protection. Br J Pharmacol 169:493–511
38. Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, Maneval DR, Quinlivan EP, Li Z, Bailey LB, Berry RJ (2011) MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr 93:1365–1372
39. Office of Dietary Supplements National Institutes of Health (2013) Dietary supplement fact sheet. http://ods.od.nih.gov/factsheets/list-all/
40. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C (2009) Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 30:6–15
41. Loscalzo J (2006) Homocysteine trials—clear outcomes for complex reasons. N Engl J Med 354:1629–1632